Drug Detail:Flumist quadrivalent (Influenza virus vaccine (nasal))
Generic Name: INFLUENZA A VIRUS A/CALIFORNIA/7/2009
Dosage Form: intranasal spray
Drug Class: Viral vaccines
FOR INTRANASAL ADMINISTRATION BY A HEALTH CARE PROVIDER.
2.1 Dosing Information
FluMist should be administered according to the following schedule:
|
||
| Age Group | Vaccination Status | Dosage Schedule |
| Children age 2 years through 8 years |
Not previously vaccinated with influenza vaccine | 2 doses (0.2 mL* each, at least 1 month apart) |
| Children age 2 years through 8 years |
Previously vaccinated with influenza vaccine | 1 dose (0.2 mL*) |
| Children, adolescents and adults age 9 through 49 years | Not applicable | 1 dose (0.2 mL*) |
For children age 2 years through 8 years who have not previously received influenza vaccine, the recommended dosage schedule for nasal administration is one 0.2 mL dose (0.1 mL per nostril), followed by a second 0.2 mL dose (0.1 mL per nostril) given at least 1 month later.
For all other individuals, including children age 2-8 years who have previously received influenza vaccine, the recommended schedule is one 0.2 mL dose (0.1 mL per nostril).
FluMist should be administered prior to exposure to influenza. Annual revaccination with influenza vaccine is recommended.
2.2 Administration Instructions
Each sprayer contains a single dose of FluMist; approximately one-half of the contents should be administered into each nostril. Refer to the administration diagram (Figure 1) for step-by-step administration instructions. Once FluMist has been administered, the sprayer should be disposed of according to the standard procedures for medical waste (e.g., sharps container or biohazard container).
Figure 1
